Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.